Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Genpact
G
$6.26B
| $7.07M | 0.01% |
331,301
+228,050
| +221% | +$5.11M |
|
|
ISBC
1177
DELISTED
Investors Bancorp, Inc.
ISBC
| $7.06M | 0.01% |
574,005
+71,060
| +14% | +$859K |
|
|
ORAN
1178
DELISTED
Orange
ORAN
| $7.04M | 0.01% |
458,649
+423,416
| +1,202% | +$6.83M |
|
1179
InterDigital
IDCC
$8.86B
| $7.04M | 0.01% |
123,731
+83,480
| +207% | +$4.66M |
|
1180
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.75B
| $7M | 0.01% |
+37,500
| New | +$7.66M |
|
1181
News Corp Class B
NWS
$18.8B
| $7M | 0.01% |
491,254
+98,852
| +25% | +$1.5M |
|
1182
Yelp
YELP
$1.28B
| $6.97M | 0.01% |
+161,897
| New | +$7.51M |
|
1183
MPLX
MPLX
$59.3B
| $6.96M | 0.01% |
97,500
-65,000
| -40% | -$4.81M |
|
|
AFFX
1184
DELISTED
Affymetrix Inc
AFFX
| $6.95M | 0.01% |
636,711
+111,272
| +21% | +$1.35M |
|
|
HZNP
1185
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.95M | 0.01% |
+200,000
| New | +$6.1M |
|
|
PRE
1186
DELISTED
PARTNERRE LTD
PRE
| $6.94M | 0.01% |
54,036
-484,356
| -90% | -$62.5M |
|
|
RBS.PRS.CL
1187
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $6.91M | 0.01% |
+276,971
| New | +$6.93M |
|
|
GI
1188
DELISTED
EndoChoice Holdings, Inc.
GI
| $6.9M | 0.01% |
+422,109
| New | +$7.01M |
|
1189
Sonida Senior Living
SNDA
$1.94B
| $6.89M | 0.01% |
18,745
-11,784
| -39% | -$4.56M |
|
1190
Tronox
TROX
$872M
| $6.87M | 0.01% |
469,692
-1,577,585
| -77% | -$29.7M |
|
1191
Enova International
ENVA
$6.11B
| $6.84M | 0.01% |
366,079
-140,060
| -28% | -$2.72M |
|
1192
Thor Industries
THO
$4.12B
| $6.83M | 0.01% |
121,367
+104,967
| +640% | +$6.35M |
|
|
FWP
1193
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $6.82M | 0.01% |
25,611
+4,091
| +19% | +$979K |
|
|
CSII
1194
DELISTED
Cardiovascular Systems, Inc.
CSII
| $6.8M | 0.01% |
+257,289
| New | +$8.31M |
|
1195
Hasbro
HAS
$13.6B
| $6.8M | 0.01% |
90,889
+32,948
| +57% | +$2.35M |
|
1196
CALL
Viatris
VTRS
$19.1B
| $6.79M | 0.01% |
+100,000
| New | +$7.07M |
|
1197
California Water Service
CWT
$3.12B
| $6.77M | 0.01% |
296,415
-74,308
| -20% | -$1.78M |
|
|
QLGC
1198
DELISTED
QLOGIC CORP
QLGC
| $6.77M | 0.01% |
476,999
+421,649
| +762% | +$6.34M |
|
1199
Norfolk Southern
NSC
$79B
| $6.76M | 0.01% |
77,407
-23,153
| -23% | -$2.26M |
|
1200
Ternium
TX
$10.7B
| $6.76M | 0.01% |
390,360
+376,636
| +2,744% | +$7.42M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.